Red X iconGreen tick iconYellow tick icon
  • Gardiner SJ, Begg EJ, Barclay ML, Kirkpatrick CMJ. Genetic polymorphism and outcomes with azathioprine and 6-mercaptopurine. Adverse Drug React Toxicol Rev 2000; 19(4), 293-312 [Abstract]
  • Stedman CA, Barclay ML. Comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther 2000; 14(8), 963-78 [Abstract]
  • Begg EJ, Robson RA, Saunders DA, Graham GG, Buttimore RC, Neill AM, Town GI. The pharmacokinetics of oral fleroxacin and ciprofloxacin in plasma and sputum during acute and chronic dosing. Br J Clin Pharmacol 2000; 49(1), 32-8 [Abstract]
  • Yee JV, Duffull SB. The effect of body weight on dalteparin pharmacokinetics - a preliminary study. Eur J Clin Pharmacol 2000; 56, 293-7 [Abstract]
  • Martin J, Begg E. Reference pricing – is it in the public interest? NZ Med J 2000; 113(1119), 422-5 [Abstract]
  • Swinburn B, Milne RJ, Richards M, Begg E, Foote S. Reimbursement of pharmaceuticals in New Zealand: comments on PHARMAC's processes. NZ Med J 2000; 113(1119), 425-8 [Abstract]
Back to top